2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$22.14+$0.37 (+1.68%)
Price as of Oct 02, 2026 4:00 PM EDT- $10.9BMarket Cap
- 6.35%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$22.14+$0.37 (+1.68%)
ELAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.77 | ||
Change | -$0.62 (-2.77%) | ||
Open | $22.32 | ||
High | $22.50 | ||
Low | $21.62 | ||
Previous Close | $22.39 | ||
Volume | 5,850,634 | ||
30-Day Average Volume | 5,599,748 | ||
1-Week Change | -2.60% | ||
1-Month Change | -8.95% | ||
1-Year Change | 6.35% | ||
3-Year Change | 93.68% | ||
5-Year Change | -32.16% | ||
Fundamentals | |||
Shares Outstanding | 499.6M | ||
Total Assets | $13.6B | ||
Market Cap | $10.9B | ||
Enterprise Value | $14.3B | ||
Period: QTR TTM FY | |||
Revenue | $1.4B | ||
Net Income | $54.0M | ||
Free Cash Flow | $244.0M | ||
EBIT | $56.0M | ||
EBITDA | $227.0M | ||
Net Working Capital | $1.9B | ||
EPS | $0.11 | ||
Enterprise Value/EBITDA | 63 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 2 | ||
P/E | 198 | ||
PEG | N/A | ||
Price/Free Cash Flow | 45 | ||
Price/Operating Cash Flow | 39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue